Biogen BIIB Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $1.29B-53.4% | $3.38B+30.2% | $3.01B+26.7% | $3.86B+127% | $2.76B+44.5% | ||
| $0— | $900M— | $807.2M— | $97.6M— | —— | ||
| $135.7M-9.9% | $139.5M+18.8% | $145.4M+54.8% | $162.3M+71.7% | $150.6M+35.3% | ||
| $7.31B-8.3% | $9.19B+20.5% | $8.97B+20.3% | $8.94B+30.8% | $7.97B+12.1% | ||
| $2.99B-3.4% | $3.02B-3.7% | $3.06B-4.0% | $3.08B-4.2% | $3.1B-4.6% | ||
| $6.99B+7.7% | $6.49B+0.2% | $6.49B+0.2% | $6.49B+0.1% | $6.49B+4.3% | ||
| $11.72B+52.9% | $7.25B-6.7% | $9.18B-5.3% | $7.53B-5.4% | $7.66B-4.5% | ||
| $32.09B+13.3% | $29.48B+5.2% | $29.44B+5.0% | $29.21B+3.2% | $28.33B+5.7% | ||
| $403.9M-1.1% | $358.5M-8.4% | $432M+1.8% | $413.1M-2.3% | $408.4M+15.2% | ||
| $3.92B+23.0% | $3B-43.4% | $3.35B-39.4% | $3.29B-39.4% | $3.18B+2.4% | ||
| $7.29B+16.0% | $6.29B+38.2% | $6.29B+38.3% | $6.29B+38.3% | $6.28B-0.1% | ||
| $300.1M-97.2% | $305.1M-97.2% | $305.3M-97.3% | $11B-8.0% | $10.7B-2.0% | ||
| $100K0.0% | $100K0.0% | $100K0.0% | $100K0.0% | $100K0.0% | ||
| $20.97B+4.1% | $20.87B+7.0% | $20.55B+6.7% | $20.6B+8.5% | $20.14B+8.2% | ||
| $18.85B+6.9% | $18.65B+9.9% | $18.26B+9.2% | $18.21B+11.3% | $17.63B+11.0% | ||
| $32.09B+13.3% | $29.48B+5.2% | $29.44B+5.0% | $29.21B+3.2% | $28.33B+5.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biogen's total assets?
- Biogen (BIIB) holds $32.1B in total assets, up 13.3% year over year.
- How much debt does Biogen have?
- Biogen carries $7.6B in total debt against $18.8B of shareholders' equity, a debt-to-equity ratio of 0.40.
- How much cash does Biogen have?
- Biogen holds $1.3B in cash and equivalents.
- Can Biogen cover its short-term obligations?
- Its current ratio is 1.87 — current assets exceed current liabilities.
- Where does Biogen's balance sheet data come from?
- Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
